REHOVOT, Israel & RICHMOND, Va.--(BUSINESS WIRE)--Dick Aderman, the president and CEO of HYCOR Biomedical whose career in the business side of diagnostics and healthcare spans almost four decades, has been named to the board of directors of ImmunArray, a private molecular diagnostics company co-headquartered in Rehovot, Israel and Richmond, Virginia.
“We are thrilled to have Dick join the ImmunArray board,” said Donna Edmonds, the company’s CEO and chairman of the board. “At this time when we are expanding our investor base and our commercial launch, his experience and leadership in the diagnostics industry will make him an invaluable addition to the board. His acumen within the field will help us position ImmunArray and our growing suite of pioneering diagnostic products in a way that accelerates our success. Dick and I were former colleagues, and I welcome the chance to work with him again in helping set the path for ImmunArray’s future as we enter the next phase of company growth.”
“I am very pleased to join the board of this emerging company in the fields of diagnosis and monitoring of the autoimmune and neurologic spaces,” Aderman said. “The response from both the rheumatologists and payers around their SLE-Key product launch has been very impressive, and I look forward to working with Donna and her team again.”
Aderman has been the president and CEO of HYCOR Biomedical since 2010, helping the Garden Grove, Calif.-based clinical diagnostics company broaden its product line from in vitro testing into the allergy and autoimmune arena. He formerly served as president of Given Imaging as well as president and COO of Quadraspec. He spent eight years as a member of the senior management team at Roche Diagnostics, and prior to that, he held various positions in sales, marketing and management with American Hospital Corporation, Baxter Healthcare and Dade International. Aderman also was involved with early and mid-stage start-up companies, developing disease-management software and medical devices.
Aderman served as the chairman of the board of the Indianapolis chapter of the American Heart Association. He holds BBA and BA degrees from Western Michigan University in Kalamazoo.
Co-located in Rehovot, Israel and Richmond, Va., ImmunArray is a privately funded molecular diagnostics company dedicated to the development of novel blood-based tests that support the diagnosis and management of complex acute and chronic immune and neurodegenerative diseases. The company designs and analyzes sets of biomarkers known to be linked to a particular condition and develops tests on platforms that are most appropriate to facilitate the adoption of additional tests. The company, which introduced its first commercial tests, is currently conducting research in collaboration with leading clinicians and medical centers in the U.S. and Israel. The company was a grant recipient of the GE-NFL Head Health Challenge as well as secured additional corporate research funding to conduct research into the use of biomarkers to identify traumatic brain injury. For more information about ImmunArray, visit www.immunarray.com.